Position
Chief Restructuring Officer
Company
BioXcel Therapeutics
Description
On October 30, 2026, Samir Saleem was appointed as President and Secretary of BioXcel Therapeutics. He will continue in his role as Chief Restructuring Officer and will serve as the principal executive officer of the Company. This appointment is effective as of 5:00 p.m
Quick answer
BioXcel Therapeutics Appoints Samir Saleem as President and Secretary (October 30, 2026). BioXcel Therapeutics is based in New Haven, Connecticut, United States.
- Who is the new Chief Restructuring Officer at BioXcel Therapeutics?
- BioXcel Therapeutics named Samir Saleem Chief Restructuring Officer, announced October 30, 2026.
- What did BioXcel Therapeutics announce on October 30, 2026?
- On October 30, 2026, Samir Saleem was appointed as President and Secretary of BioXcel Therapeutics. He will continue in his role as Chief Restructuring Officer and will serve as the principal executive officer of the Company.
- What does BioXcel Therapeutics do?
- BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuropsychiatric diseases.
- Where is BioXcel Therapeutics based?
- BioXcel Therapeutics is based in New Haven, Connecticut, United States.
- Which similar companies made leadership changes around the same time?
- Harmony Biosciences (October 30, 2026), Celea Therapeutics (October 29, 2026), AlzeCure Pharma (November 1, 2026) and Oculis Holding AG (November 2, 2026) also announced leadership changes within 45 days of BioXcel Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Peter Anastasiou Appointed as President and CEO of Harmony Biosciences (October 30, 2026)
- Celea Therapeutics Appoints Paul Audhya as Chief Medical Officer (October 29, 2026)
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- Oculis Appoints Björn Tackenberg as Chief Scientific Officer (November 2, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Pfizer Appoints Cecile Guegan as Chief Financial Officer (November 3, 2026)
Who to call at BioXcel Therapeutics, and when
A new leader at BioXcel Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BioXcel Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioXcel Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioXcel Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioXcel Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioXcel Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.